Organisation paid for research Program year 2025 Source: CMS Open Payments

Utah Eye Centers

Neither a doctor nor a teaching hospital

Research payments

$232,130

70 payments

Through program year 2025, Utah Eye Centers is reported as receiving $232,130 in research payments, across 70 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$8,000	2
2024	Research	$42,250	9
2023	Research	$7,430	9
2022	Research	$36,928	13
2021	Research	$46,370	14
2020	Research	$31,630	11
2019	Research	$59,521	12

Breakdown

Who paid Research payments · program years 2019–2025

Glaukos Corporation $168,087 62 payments
RxSight Inc $28,000 5 payments
Bausch & Lomb Americas Inc. $17,650 1 payment
Dompe US, Inc. $16,393 1 payment
Sight Sciences, Inc. $2,000 1 payment

Studies the money was for Research payments · program years 2019–2025

Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, USP, 0.5 $55,516 11 payments
Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, USP, 0.5 $46,370 14 payments
Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, USP, 0.5% $31,630 11 payments
Pmcs-002 $22,000 4 payments
Post-Approval Follow-Up Study of the Ic-8 Apthera Iol $17,650 1 payment
Corneal Sensitivity change post Nerve Growth Factor treatment in Diabetic Nerurotrophic Keratitis $16,393 1 payment
Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, USP, 0.5% $7,430 9 payments
Pmcs-010 $6,000 1 payment
Multicenter Investigation of Trabecular Micro-Bypass Stents vs. Laser Trabeculoplasty $4,005 1 payment
Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, USP, 0.5% $2,600 4 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.